Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 0 | 0 | 0 | 17 | 24 |
| Operating Expenses | 929 | 870 | 1,050 | 1,052 | 893 |
| Operating Income | -929 | -870 | -1,050 | -1,035 | -868 |
| Other Income | 929 | 870 | 1,050 | 1,035 | 868 |
| Net Income Continuous | -973 | -877 | -1,077 | -1,090 | -956 |
| Net Income | $-973 | $-877 | $-1,077 | $-1,090 | $-956 |
| EPS Basic Total Ops | -0.13 | -0.13 | -0.18 | -0.26 | -0.26 |
| EPS Basic Continuous Ops | -0.13 | -0.13 | -0.18 | -0.26 | -0.26 |
| EPS Diluted Total Ops | -0.13 | -0.13 | -0.18 | -0.26 | -0.26 |
| EPS Diluted Continuous Ops | -0.13 | -0.13 | -0.18 | -0.26 | -0.26 |
| EBITDA(a) | $-900 | $-831 | $-1,008 | $-929 | $-833 |